Intervention

fluorouracil

ClinicalTrials.gov intervention label

Clinical trials59

Recruiting0

Common conditions25

Lead sponsors shown15

Clinical trials

59 shown

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.NCT05355701 · 2022-07-05

ACTIVE_NOT_RECRUITING

PEN-866 in Patients With Advanced Solid MalignanciesNCT03221400 · 2017-08-29

Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin LesionsNCT02059499 · 2015-12-28

Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade LesionsNCT02135419 · 2014-09-24

Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast CancerNCT02115152 · 2014-06-01

Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast CancerNCT01880385 · 2011-03-01

Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by SurgeryNCT00936832 · 2009-04-01

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast CancerNCT01093235 · 2009-04-01

Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer PatientsNCT00820547 · 2009-01-01

Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By SurgeryNCT00963729 · 2008-09-01

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast CancerNCT00629278 · 2007-12-01

Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic CancerNCT01068327 · 2007-11-05

Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast CancerNCT00630032 · 2007-09-01

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or LungNCT00557102 · 2007-09-01

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryNCT00513266 · 2007-06-01

Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast CancerNCT00872625 · 2007-04-01

Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal CancerNCT00324415 · 2006-09-01

Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast CancerNCT00533936 · 2006-09-01

Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast CancerNCT00429299 · 2006-08-01

Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By SurgeryNCT00301925 · 2005-12-16

AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal CancerNCT00343408 · 2005-11-29

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast CancerNCT00087178 · 2004-05-01

Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast CancerNCT00309920 · 2004-01-01

Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By SurgeryNCT00311636 · 2003-09-01

Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast CancerNCT00433420 · 2003-04-01

ACTIVE_NOT_RECRUITING

Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast CancerNCT00053911 · 2002-11-01

Combination Chemotherapy in Treating Women With Stage I Breast CancerNCT00055679 · 2002-08-01

Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid TumorsNCT00044785 · 2002-08-01

Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast CancerNCT00036868 · 2002-02-01

Combination Chemotherapy in Treating Women With Breast CancerNCT00047099 · 2001-08-01

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast CancerNCT00017095 · 2001-03-01

Combination Chemotherapy in Treating Women With Resected Breast CancerNCT00033683 · 2001-02-01

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast CancerNCT00014222 · 2000-12-04

Combination Chemotherapy in Treating Women With Stage II or Stage III Breast CancerNCT00005581 · 2000-06-01

Combination Chemotherapy in Treating Older Women With Metastatic Breast CancerNCT00010075 · 2000-01-01

Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast CancerNCT00012311 · 2000-01-01

Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast CancerNCT00003730 · 1998-12-01

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast CancerNCT00003680 · 1998-11-01

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasNCT00019513 · 1998-08-01

Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast CancerNCT00003893 · 1998-07-01

Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009)NCT01031030 · 1997-11-01

Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical CancerNCT00003135 · 1997-11-01

Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast CancerNCT00003086 · 1997-03-01

Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With SurgeryNCT00015886 · 1997-01-01

Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast CancerNCT00003012 · 1996-10-01

Chemotherapy Plus Surgery in Treating Women With Breast CancerNCT00003013 · 1996-10-01

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast CancerNCT00002784 · 1996-06-01

Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast CancerNCT00003577 · 1996-03-01

Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast CancerNCT00002755 · 1995-11-01

Combination Chemotherapy in Treating Women With Stage III Breast CancerNCT00002696 · 1995-10-01

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast CancerNCT00002870 · 1994-12-01

Tamoxifen in Treating Women With High-Risk Breast CancerNCT00002542 · 1993-07-20

Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast CancerNCT00002582 · 1993-06-01

Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast CancerNCT00002581 · 1993-06-01

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast CancerNCT00002580 · 1993-06-01

Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast CancerNCT00002579 · 1993-03-01

Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast CancerNCT00002498 · 1992-07-01

Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid TumorsNCT00002470 · 1990-09-01

SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast CancerNCT00929591 · 1989-05-01

Common conditions

Leading sponsors

Scottish Cancer Therapy Network6 UNICANCER5 AIDS Malignancy Consortium3 European Organisation for Research and Treatment of Cancer - EORTC3 Institute of Cancer Research, United Kingdom3 NCIC Clinical Trials Group3 IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy2 University Hospital Birmingham2 Association Tunisienne de lutte Contre le Cancer1 Azienda Ospedaliero-Universitaria di Modena1 Cambridge University Hospitals NHS Foundation Trust1 Centre Antoine Lacassagne1 Centre Hospitalier Universitaire Vaudois1 ETOP IBCSG Partners Foundation1 Federation Francophone de Cancerologie Digestive1

Trial status mix

COMPLETED35

UNKNOWN17

TERMINATED3

ACTIVE_NOT_RECRUITING2

SUSPENDED1

WITHDRAWN1

Phase mix

PHASE332

PHASE218

PHASE19

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.